The FDA warned consumers against infusions of plasma from young donors, saying there is no evidence that they slow aging or memory loss, and can be dangerous.
इंडिया ताज़ा खबर, इंडिया मुख्य बातें
Similar News:आप इससे मिलती-जुलती खबरें भी पढ़ सकते हैं जिन्हें हमने अन्य समाचार स्रोतों से एकत्र किया है।
'Young blood' company Ambrosia halts patient treatments after FDA warningThe FDA warned consumers against infusions of plasma from young donors, saying there is no evidence that they slow aging or memory loss, and can be dangerous.
और पढो »
FDA warns against blood transfusions from young donors as anti-aging treatmentA growing number of clinics offer blood transfusions that use the plasma of young donors to treat symptoms of aging, and other serious health conditions, such as dementia and heart disease.
और पढो »
'Young blood' treatments to stop aging, disease are a 'significant public health concern': FDA
और पढो »
FDA discourages people against 'young blood' infusions, which make unproven claims to reverse agingThe FDA is advising against 'young blood' infusions, in which people are infused with plasma from young donors. It warns consumers that clinics are making unproven claims that the treatment can reverse aging.
और पढो »